Fighting Food Allergy: Current Approaches

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2005-11-01

• Fields of study

  Agricultural and Food Sciences, Medicine

• Identifiers
  DOI 10.1196/annals.1352.003PMID 16387675
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives

  2008cited by this paper
• Anti-IgE for chronic asthma in adults and children.

  2006cited by this paper
• Allergen immunotherapy with heat‐killed Listeria monocytogenes alleviates peanut and food‐induced anaphylaxis in dogs

  2005cited by this paper
• Development of Allergic Airway Disease in Mice following Antibiotic Therapy and Fungal Microbiota Increase: Role of Host Genetics, Antigen, and Interleukin-13

  2005cited by this paper
• The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy.

  2005cited by this paper
• Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis *

  2005cited by this paper
• Probiotics: an emerging therapy.

  2005cited by this paper
• DNA vaccines for allergy treatment.

  2004cited by this paper
• Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy.

  2004cited by this paper
• Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA.

  2004cited by this paper
• Animal models of type I allergy using recombinant allergens.

  2004cited by this paper
• Prevention of long-term IgE antibody production by gene gun-mediated DNA vaccination.

  2004cited by this paper
• Efficacy of birch‐pollen immunotherapy on cross‐reactive food allergy confirmed by skin tests and double‐blind food challenges

  2004cited by this paper
• Current and potential uses of probiotics.

  2004cited by this paper
• New approaches for treatment of peanut allergy

  2004cited by this paper
• Cow's milk-specific T-cell reactivity of children with and without persistent cow's milk allergy: key role for IL-10.

  2004cited by this paper
• Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double‐blind placebo‐controlled study

  2004cited by this paper
• Immunological mechanisms in specific immunotherapy

  2004cited by this paper
• Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis.

  2004cited by this paper
• Update on food allergy.

  2004cited by this paper
• Inhibition of allergen-specific IgE reactivity by a human Ig Fcgamma-Fcepsilon bifunctional fusion protein.

  2004cited by this paper
• Aluminium hydroxide down‐regulates T helper 2 responses by allergen‐stimulated human peripheral blood mononuclear cells

  2004cited by this paper
• Efficacy and safety of sublingual immunotherapy.

  2004cited by this paper
• Update on threshold doses of food allergens: implications for patients and the food industry

  2004cited by this paper
• Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model.

  2004cited by this paper
• Toll-Like Receptor 4 Signaling by Intestinal Microbes Influences Susceptibility to Food Allergy1

  2004cited by this paper
• Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy.

  2004cited by this paper
• Probiotics and medical nutrition therapy.

  2004cited by this paper
• Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.

  2004cited by this paper
• Prevalence of seafood allergy in the United States determined by a random telephone survey.

  2004cited by this paper
• Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut

  2004cited by this paper
• Inhibition of allergen-specific IgE reactivity by a human Ig Fcγ-Fcε bifunctional fusion protein

  2004cited by this paper
• Soy immunotherapy for peanut-allergic mice: modulation of the peanut-allergic response.

  2004cited by this paper
• Lymphocytes in Peyer patches regulate clinical tolerance in a murine model of food allergy.

  2004cited by this paper
• Vaccination with genetically engineered allergens prevents progression of allergic disease

  2004cited by this paper
• Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.

  2004cited by this paper
• Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin.

  2004cited by this paper
• Improving diagnostic tests for food allergy with recombinant allergens.

  2004cited by this paper
• Distribution of peanut allergen in the environment.

  2004cited by this paper
• Food allergy to apple and specific immunotherapy with birch pollen.

  2004cited by this paper
• Therapeutic potential of IL-10 and its viral homologues: an update

  2003cited by this paper
• Thresholds of clinical reactivity to milk, egg, peanut and sesame in immunoglobulin E‐dependent allergies: evaluation by double‐blind or single‐blind placebo‐controlled oral challenges

  2003cited by this paper
• TH1-promoting DNA immunization against allergens modulates the ratio of IgG1/IgG2a but does not affect the anaphylactic potential of IgG1 antibodies: no evidence for the synthesis of nonanaphylactic IgG1.

  2003cited by this paper
• Allergen‐specific immunotherapy with a monophosphoryl lipid A‐adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy‐induced blocking antibodies

  2003cited by this paper
• Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics.

  2003cited by this paper
• Oral Administration of Probiotic Escherichia coli after Birth Reduces Frequency of Allergies and Repeated Infections Later in Life (after 10 and 20 Years)

  2003cited by this paper
• Engineered Recombinant Peanut Protein and Heat-Killed Listeria monocytogenes Coadministration Protects Against Peanut-Induced Anaphylaxis in a Murine Model1

  2003cited by this paper
• Interleukin-10 Therapy—Review of a New Approach

  2003cited by this paper
• Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.

  2003cited by this paper
• Aspirin desensitization in patients with AERD

  2003cited by this paper
• Is there a role for anti-IgE in combination with specific allergen immunotherapy?

  2003cited by this paper
• Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts.

  2003cited by this paper
• Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double‐blind, randomized, placebo‐controlled trial

  2003cited by this paper
• Cytokine traps: multi-component, high-affinity blockers of cytokine action

  2003cited by this paper
• Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy.

  2003cited by this paper
• Effect of probiotic lactobacillus strains in children with atopic dermatitis

  2003cited by this paper
• Effect of anti-IgE therapy in patients with peanut allergy.

  2003cited by this paper
• The cow's milk protein‐specific T cell response in infancy and childhood

  2003cited by this paper
• Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study.

  2003cited by this paper
• A survey on the management of pollen-food allergy syndrome in allergy practices.

  2003cited by this paper
• Side‐effects of complementary and alternative medicine

  2003cited by this paper
• 9. Food allergy.

  2003cited by this paper
• Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

  2003cited by this paper
• Role of intestinal flora in the development of allergy

  2003cited by this paper
• Induction of specific Th1 responses and suppression of IgE antibody formation by vaccination with plasmid DNA encoding Der f 11.

  2002cited by this paper
• Probiotics and food‐allergic diseases

  2002cited by this paper
• Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma.

  2002cited by this paper
• Probiotics against allergy: data, doubts, and perspectives

  2002cited by this paper
• The range of minimum provoking doses in hazelnut‐allergic patients as determined by double‐blind, placebo‐controlled food challenges

  2002cited by this paper
• Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model

  2002cited by this paper
• Recombinant allergen‐based concepts for diagnosis and therapy of Type I allergy

  2002cited by this paper
• Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1 : Th2 cytokine ratios

  2002cited by this paper
• Probiotics and atopic dermatitis. A new strategy in atopic dermatitis.

  2002cited by this paper
• An Enteric Helminth Infection Protects Against an Allergic Response to Dietary Antigen1

  2002cited by this paper
• Immunostimulatory DNA‐based therapeutics for experimental and clinical allergy

  2002cited by this paper
• Atopic Dermatitis

  2002cited by this paper
• A novel human immunoglobulin Fcγ–Fcɛ bifunctional fusion protein inhibits FcɛRI-mediated degranulation

  2002cited by this paper
• Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis.

  2002cited by this paper
• Animal models of food allergy

  2002cited by this paper
• Harmful effect of immunotherapy in children with combined snail and mite allergy.

  2002cited by this paper
• Animal models of food allergy.

  2002cited by this paper
• A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation.

  2002cited by this paper
• Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen

  2001cited by this paper
• IL-13 Overexpression Predisposes to Anaphylaxis Following Antigen Sensitization1

  2001cited by this paper
• Oral administration of IL-12 suppresses anaphylactic reactions in a murine model of peanut hypersensitivity.

  2001cited by this paper
• Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy.

  2001cited by this paper
• Antigen-Independent Suppression of the Allergic Immune Response to Bee Venom Phospholipase A2 by DNA Vaccination in CBA/J Mice1

  2001cited by this paper
• Efficacy of soluble IL-4 receptor for the treatment of adults with asthma.

  2001cited by this paper
• Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

  2001cited by this paper
• Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial.

  2001cited by this paper
• The effect of vaccination with DNA encoding murine T‐cell epitopes on the Der p 1 and 2 induced immunoglobulin E synthesis

  2001cited by this paper
• Interleukin‐10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy

  2001cited by this paper
• Oral Carrageenan Induces Antigen-Dependent Oral Tolerance: Prevention of Anaphylaxis and Induction of Lymphocyte Anergy in a Murine Model of Food Allergy

  2001cited by this paper
• Genetic Immunisation with Bovine β-Lactoglobulin cDNA Induces a Preventive and Persistent Inhibition of Specific Anti-BLG IgE Response in Mice

  2001cited by this paper
• Food Allergy Herbal Formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model.

  2001cited by this paper
• A well‐tolerated grass pollen‐specific allergy vaccine containing
a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections

  2001cited by this paper
• Vaccination with Allergen-IL-18 Fusion DNA Protects Against, and Reverses Established, Airway Hyperreactivity in a Murine Asthma Model1

  2001cited by this paper
• Bacterial CpG-DNA Triggers Activation and Maturation of Human CD11c−, CD123+ Dendritic Cells1

  2001cited by this paper
• Fatalities due to anaphylactic reactions to foods.

  2001cited by this paper
• Safety evaluation of a glutaraldehyde modified tyrosine adsorbed housedust mite extract containing monophosphoryl lipid A (MPL) adjuvant: a new allergy vaccine for dust mite allergy.

  2001cited by this paper

• Research progress and immunological insights of shrimp allergens.

  2024cites this paper
• Assessment of allergenicity of irradiated dairy products in a Balb/c mice model

  2020cites this paper
• Effect of 3 lactobacilli on immunoregulation and intestinal microbiota in a β-lactoglobulin-induced allergic mouse model.

  2019cites this paper
• Allergenicity of bony and cartilaginous fish – molecular and immunological properties

  2017cites this paper
• Overcoming the interruptible nature of allergy treatment through applying knowledge management principles: A Trip from raw knowledge to transferable wisdom

  2016cites this paper
• Low-Dose IL-2 Induces Regulatory T Cell–Mediated Control of Experimental Food Allergy

  2016cites this paper
• Current advances of murine models for food allergy.

  2016cites this paper
• Parvalbumin: characterisation of the cross-reactive major fish allergen

  2015cites this paper
• Food Omics Validation: Towards Understanding Key Features for Gut Microbiota, Probiotics and Human Health

  2015cites this paper
• Fish Allergy: In Review

  2014cites this paper
• The dichotomy of pathogens and allergens in vaccination approaches

  2014cites this paper
• Evaluation and integration of existing methods for computational prediction of allergens

  2013cites this paper
• 8 – Vaccine safety and quality assessments

  2013cites this paper
• The pivotal role of mass spectrometry in determining the presence of chemical contaminants in food raw materials.

  2011cites this paper
• Differential responses to natural and recombinant allergens in a murine model of fish allergy.

  2011cites this paper
• Prevalence, Natural History, Diagnosis, and Treatment of Food Allergy

  2010cites this paper
• Vitamin C: An immunomodulator that attenuates anaphylactic reactions to soybean glycinin hypersensitivity in a swine model

  2009cites this paper
• Crystal structure of prunin-1, a major component of the almond (Prunus dulcis) allergen amandin.

  2009cites this paper
• The value of position-specific scoring matrices for assessment of protein allegenicity

  2008cites this paper
• Prediction of protein allergenicity using local description of amino acid sequence.

  2008cites this paper
• Methods and protocols for the assessment of protein allergenicity and cross-reactivity.

  2008cites this paper
• Allergy and asthma to indigenous seafood species in South Africa : review article

  2007cites this paper
• SEAFOOD HARVESTED IN SOUTH AFRICA AND AGENTS IMPLICATED IN ADVERSE REACTIONS

  2007cites this paper
• AllerTool: a web server for predicting allergenicity and allergic cross-reactivity in proteins

  2007cites this paper
• Analysis of soybean-proteins (Glycine max) by two-dimensional electrophoresis and MALDI-TOF

  2006cites this paper
• Analysis of soybean-proteins (Glycine max) by two-dimensional electrophoresis and MALDI-TOF

  2006cites this paper
• Food allergy in gastroenterologic diseases: Review of literature.

  2006cites this paper